DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
417-425
Author(s):
Mark R. Kelley and Melissa L. Fishel
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
426-430
Author(s):
Rachel Litman, Rigu Gupta, Robert M. Brosh, Jr. and Sharon B. Cantor
Repair and Translesion DNA Polymerases as Anticancer Drug Targets
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
431-447
Author(s):
Giovanni Maga and Ulrich Hubscher
Therapeutic Exploitation of Tumor Cell Defects in Homologous Recombination
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
448-460
Author(s):
Simon N. Powell and Lisa A. Kachnic
High-Content Screening and Mechanism-Based Evaluation of Estrogenic Botanical Extracts
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
11
Page:
283-293
Author(s):
Cassia R. Overk, Ping Yao, Shaonong Chen, Shixing Deng, Ayano Imai, Matthew Main, Andreas Schinkovitz, Norman R. Farnsworth, Guido F. Pauli and Judy L. Bolton
Editorial [Hot Topic: Environmental Impacts on Enzymes Involved in Drug and Steroid Metabolism Guest Editor: R.H. Waring ]
Journal:
Current Drug Metabolism
Volume:
9
Page:
267-268
Author(s):
R. H. Waring
Estrogenic Phenol and Catechol Metabolites of PCBs Modulate Catechol-Omethyltransferase Expression Via the Estrogen Receptor: Potential Contribution to Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
304-309
Author(s):
P. W.L. Ho, C. E. Garner, J. W.M. Ho, K. C. Leung, A. C.Y. Chu, K. H.H. Kwok, M. H.W. Kung, L. T. Burka, D. B. Ramsden and S. L. Ho
A Carboxylesterase 2 Gene Polymorphism as Predictor of Capecitabine on Response and Time to Progression
Journal:
Current Drug Metabolism
Volume:
9
Page:
336-343
Author(s):
N. Ribelles, J. Lopez-Siles, A. Sanchez, E. Gonzalez, M. J. Sanchez, F. Carabantes, P. Sanchez-Rovira, A. Marquez, R. Duenas, I. Sevilla and E. Alba
Many Drugs and Phytochemicals Can Be Activated to Biological Reactive Intermediates
Journal:
Current Drug Metabolism
Volume:
9
Page:
344-351
Author(s):
William W. Johnson
Potential Benefits of Glitazones for Cancer and Vascular Disease
Journal:
Current Drug Therapy
Volume:
3
Page:
111-125
Author(s):
Jose M. Perez-Ortiz, Silvia Llorens, Juan Llopis, Pedro A. Tranque and Eduardo Nava